As of 2025-10-29, the Relative Valuation of Inovio Pharmaceuticals Inc (INO) is (35.71) USD. This relative valuation is based on P/E multiples. With the latest stock price at 2.58 USD, the upside of Inovio Pharmaceuticals Inc based on Relative Valuation is -1484.3%.
The range of the Relative Valuation is (30.82) - (36.60) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 17.2x - 22.2x | 19.7x |
| Forward P/E multiples | 18.7x - 28.4x | 23.6x |
| Fair Price | (30.82) - (36.60) | (35.71) |
| Upside | -1294.5% - -1518.5% | -1484.3% |
| Date | P/E |
| 2025-10-16 | -1.49 |
| 2025-10-15 | -1.54 |
| 2025-10-14 | -1.48 |
| 2025-10-13 | -1.50 |
| 2025-10-10 | -1.56 |
| 2025-10-09 | -1.60 |
| 2025-10-08 | -1.55 |
| 2025-10-07 | -1.45 |
| 2025-10-06 | -1.46 |
| 2025-10-03 | -1.47 |
| 2025-10-02 | -1.49 |
| 2025-10-01 | -1.44 |
| 2025-09-30 | -1.42 |
| 2025-09-29 | -1.48 |
| 2025-09-26 | -1.50 |
| 2025-09-25 | -1.47 |
| 2025-09-24 | -1.53 |
| 2025-09-23 | -1.46 |
| 2025-09-22 | -1.51 |
| 2025-09-19 | -1.39 |
| 2025-09-18 | -1.40 |
| 2025-09-17 | -1.32 |
| 2025-09-16 | -1.38 |
| 2025-09-15 | -1.38 |
| 2025-09-12 | -1.44 |
| 2025-09-11 | -1.60 |
| 2025-09-10 | -1.60 |
| 2025-09-09 | -1.67 |
| 2025-09-08 | -1.74 |
| 2025-09-05 | -1.69 |
| 2025-09-04 | -1.67 |
| 2025-09-03 | -1.64 |
| 2025-09-02 | -1.56 |
| 2025-08-29 | -1.44 |
| 2025-08-28 | -1.49 |
| 2025-08-27 | -1.49 |
| 2025-08-26 | -1.24 |
| 2025-08-25 | -1.18 |
| 2025-08-22 | -1.19 |
| 2025-08-21 | -1.16 |
| 2025-08-20 | -1.12 |
| 2025-08-19 | -1.17 |
| 2025-08-18 | -1.15 |
| 2025-08-15 | -1.13 |
| 2025-08-14 | -0.98 |
| 2025-08-13 | -1.03 |
| 2025-08-12 | -0.90 |
| 2025-08-11 | -0.87 |
| 2025-08-08 | -0.85 |
| 2025-08-07 | -0.87 |